Is Inari Medical Stock a Good Investment?
Inari Medical Investment Advice | NARI |
- Examine Inari Medical's financial health by looking at its balance sheet, income statement, and cash flow statement. Analyze key financial ratios, such as Price-to-Earnings (P/E), Price-to-Sales (P/S), and Price-to-Book (P/B), to determine whether the stock is fairly valued or over/undervalued.
- Research Inari Medical's leadership team and their track record. Good management can help Inari Medical navigate difficult times and make strategic decisions that benefit shareholders and increases its net worth.
- Consider the overall health of the Health Care Equipment & Supplies space and any emerging trends that could impact Inari Medical's business and its evolving consumer preferences.
- Compare Inari Medical's performance and market position to its competitors. Analyze how Inari Medical is positioned in terms of product offerings, innovation, and market share.
- Check if Inari Medical pays a dividend and its dividend yield and payout ratio.
- Review what financial analysts are saying about Inari Medical's stock and their price targets. However, remember that analysts' opinions can vary, and their predictions may not always be accurate.
It's important to note that investing in Inari Medical stock, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember that it's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. Below is a detailed guide on how to decide if Inari Medical is a good investment.
Sell | Buy |
Hold
Market Performance | Good | Details | |
Volatility | Very steady | Details | |
Hype Condition | Low key | Details | |
Current Valuation | Overvalued | Details | |
Odds Of Distress | Low | Details | |
Economic Sensitivity | Moves slightly opposite to the market | Details | |
Investor Sentiment | Alarmed | Details | |
Analyst Consensus | Buy | Details | |
Financial Strenth (F Score) | Poor | Details | |
Financial Leverage | Not Rated | Details | |
Reporting Quality (M-Score) | Unlikely Manipulator | Details |
Examine Inari Medical Stock
Researching Inari Medical's stock involves analyzing various aspects of the company and its industry to make an informed investment decision. The key areas to focus on are fundamentals, business model and competitive advantage. It is also important to analyze trends in revenue, net income, and cash flow, as well as key financial ratios, such as price-to-earnings (P/E), price-to-sales (P/S), and debt-to-equity (D/E). About 97.0% of the company shares are owned by institutional investors. The company has Price/Earnings (P/E) ratio of 275.35. Inari Medical recorded a loss per share of 1.35. The entity had not issued any dividends in recent years.
To determine if Inari Medical is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding Inari Medical's research are outlined below:
| Inari Medical is way too risky over 90 days horizon | |
| Inari Medical appears to be risky and price may revert if volatility continues | |
| The company reported the previous year's revenue of 493.63 M. Net Loss for the year was (1.64 M) with profit before overhead, payroll, taxes, and interest of 498.76 M. | |
| Inari Medical has a poor financial position based on the latest SEC disclosures | |
| Over 97.0% of the company shares are owned by institutional investors | |
| Latest headline from thelincolnianonline.com: Disposition of 141075 shares by William Hoffman of Inari Medical at 60.13 subject to Rule 16b-3 |
Inari Medical Quarterly Cash And Short Term Investments |
|
Inari Medical uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in Inari Medical. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Inari Medical's previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
| 26th of February 2024 Upcoming Quarterly Report | View | |
| 1st of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 26th of February 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Earnings surprises can significantly impact Inari Medical's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate. Below are the table of largest EPS Surprises Inari Medical's investors have experienced.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2022-02-23 | 2021-12-31 | 0.03 | 0.02 | -0.01 | 33 | ||
2021-08-10 | 2021-06-30 | 0.08 | 0.07 | -0.01 | 12 | ||
2024-04-30 | 2024-03-31 | -0.2 | -0.22 | -0.02 | 10 | ||
2020-08-11 | 2020-06-30 | -0.18 | -0.16 | 0.02 | 11 | ||
2022-05-04 | 2022-03-31 | -0.09 | -0.06 | 0.03 | 33 | ||
2024-10-28 | 2024-09-30 | -0.13 | -0.09 | 0.04 | 30 | ||
2022-08-03 | 2022-06-30 | -0.23 | -0.19 | 0.04 | 17 | ||
2021-11-09 | 2021-09-30 | -0.11 | -0.06 | 0.05 | 45 |
Inari Medical Target Price Consensus
Inari target price is determined by taking all analyst projections and averaging them out. There is no one specific way to measure analysts' performance other than comparing it to past results via a very sophisticated attribution analysis. Inari Medical's target price projections below should be used in combination with other traditional price prediction techniques such as stock price forecasting, investor sentiment analysis, technical analysis, earnings estimate, and various momentum models.
| 14 | Buy |
Most Inari analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to help potential investors understand Inari stock's fair price compared to its market value. Analysts arrive at stock ratings after researching the public financial statements of Inari Medical, talking to its executives and customers, or listening to those companies' conference calls.
Macroaxis Advice Exposure ValuationInari Medical Target Price Projection
Inari Medical's current and average target prices are 79.69 and 74.12, respectively. The current price of Inari Medical is the price at which Inari Medical is currently trading. On the other hand, Inari Medical's target price is what analysts think the stock is worth or could sell for in the future. The more significant the discrepancy between the two prices, the more it stimulates investors to act.Current Price
Inari Medical Market Quote on 31st of January 2025
Target Price
Analyst Consensus On Inari Medical Target Price
Inari Medical Analyst Ratings
Inari Medical's analyst stock recommendations are determined by taking an average estimate of all analysts we track and classifying them as Strong Buy, Buy, Hold, Strong Sell, or Sell. Ratings generally communicate what analysts sense about Inari Medical stock, and they use a lot of effort and time to analyze it and arrive at a rating. That suggests that analyst recommendations are the outcome of an objective and thorough examination of Inari Medical's financials, market performance, and future outlook by experienced professionals. Inari Medical's historical ratings below, therefore, can serve as a valuable tool for investors.Know Inari Medical's Top Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Inari Medical is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Inari Medical backward and forwards among themselves. Inari Medical's institutional investor refers to the entity that pools money to purchase Inari Medical's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Jpmorgan Chase & Co | 2024-09-30 | 1.1 M | Bamco Inc | 2024-09-30 | 1 M | American Century Companies Inc | 2024-09-30 | 979.4 K | Millennium Management Llc | 2024-09-30 | 959.2 K | Mackenzie Investments | 2024-09-30 | 853.8 K | Point72 Asset Management, L.p. | 2024-09-30 | 805.6 K | Bank Of America Corp | 2024-09-30 | 803.1 K | Manufacturers Life Insurance Co | 2024-09-30 | 795.1 K | Fuller & Thaler Asset Management Inc | 2024-09-30 | 768.5 K | Blackrock Inc | 2024-09-30 | 8.3 M | Vanguard Group Inc | 2024-09-30 | 5.6 M |
Inari Medical's market capitalization trends
The company currently falls under 'Mid-Cap' category with a current market capitalization of 4.67 B.Market Cap |
|
Inari Medical's profitablity analysis
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | 0.00 | (0.01) | |
| Return On Capital Employed | (0.02) | (0.02) |
Determining Inari Medical's profitability involves analyzing its financial statements and using various financial metrics to determine if Inari Medical is a good buy. For example, gross profit margin measures Inari Medical's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of Inari Medical's profitability and make more informed investment decisions.
Inari Medical's Earnings Breakdown by Geography
Evaluate Inari Medical's management efficiency
Inari Medical has return on total asset (ROA) of (0.0321) % which means that it has lost $0.0321 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.1772) %, meaning that it created substantial loss on money invested by shareholders. Inari Medical's management efficiency ratios could be used to measure how well Inari Medical manages its routine affairs as well as how well it operates its assets and liabilities. The current Return On Tangible Assets is estimated to decrease to -0.005. The current Return On Capital Employed is estimated to decrease to -0.02. As of now, Inari Medical's Non Currrent Assets Other are increasing as compared to previous years. The Inari Medical's current Other Assets is estimated to increase to about 949.3 K, while Other Current Assets are projected to decrease to under 6 M.| Last Reported | Projected for Next Year | ||
| Book Value Per Share | 7.37 | 7.74 | |
| Tangible Book Value Per Share | 1.58 | 2.54 | |
| Enterprise Value Over EBITDA | 278.58 | 264.65 | |
| Price Book Value Ratio | 7.13 | 7.49 | |
| Enterprise Value Multiple | 278.58 | 264.65 | |
| Price Fair Value | 7.13 | 7.49 | |
| Enterprise Value | 3.3 B | 2.4 B |
The strategic initiatives led by Inari Medical's management are central to its market success. By analyzing these initiatives, we provide a clear picture of the stock's growth prospects.
Beta 0.963 |
Basic technical analysis of Inari Stock
As of the 31st of January, Inari Medical retains the Risk Adjusted Performance of 0.1677, market risk adjusted performance of (1.95), and Downside Deviation of 2.07. Concerning fundamental indicators, the technical analysis model lets you check existing technical drivers of Inari Medical, as well as the relationship between them.Inari Medical's insider trading activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Inari Medical insiders, such as employees or executives, is commonly permitted as long as it does not rely on Inari Medical's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Inari Medical insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Inari Medical's Outstanding Corporate Bonds
Inari Medical issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Inari Medical uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Inari bonds can be classified according to their maturity, which is the date when Inari Medical has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
Understand Inari Medical's technical and predictive indicators
Using predictive indicators to make investment decisions involves analyzing Inari Medical's various financial and market-based factors to help forecast future trends and identify investment opportunities. Select the indicators that are most relevant to your investment strategy. Each indicator has its own strengths and weaknesses, so it's essential to combine multiple indicators to get a more comprehensive view of the market and reduce the risk of making poor decisions based on limited data.
| Risk Adjusted Performance | 0.1677 | |||
| Market Risk Adjusted Performance | (1.95) | |||
| Mean Deviation | 2.86 | |||
| Semi Deviation | 1.41 | |||
| Downside Deviation | 2.07 | |||
| Coefficient Of Variation | 524.55 | |||
| Standard Deviation | 5.42 | |||
| Variance | 29.35 | |||
| Information Ratio | 0.1722 | |||
| Jensen Alpha | 1.07 | |||
| Total Risk Alpha | 0.4396 | |||
| Sortino Ratio | 0.4502 | |||
| Treynor Ratio | (1.96) | |||
| Maximum Drawdown | 30.79 | |||
| Value At Risk | (3.87) | |||
| Potential Upside | 6.43 | |||
| Downside Variance | 4.29 | |||
| Semi Variance | 1.98 | |||
| Expected Short fall | (3.81) | |||
| Skewness | 3.76 | |||
| Kurtosis | 16.78 |
| Risk Adjusted Performance | 0.1677 | |||
| Market Risk Adjusted Performance | (1.95) | |||
| Mean Deviation | 2.86 | |||
| Semi Deviation | 1.41 | |||
| Downside Deviation | 2.07 | |||
| Coefficient Of Variation | 524.55 | |||
| Standard Deviation | 5.42 | |||
| Variance | 29.35 | |||
| Information Ratio | 0.1722 | |||
| Jensen Alpha | 1.07 | |||
| Total Risk Alpha | 0.4396 | |||
| Sortino Ratio | 0.4502 | |||
| Treynor Ratio | (1.96) | |||
| Maximum Drawdown | 30.79 | |||
| Value At Risk | (3.87) | |||
| Potential Upside | 6.43 | |||
| Downside Variance | 4.29 | |||
| Semi Variance | 1.98 | |||
| Expected Short fall | (3.81) | |||
| Skewness | 3.76 | |||
| Kurtosis | 16.78 |
Consider Inari Medical's intraday indicators
Inari Medical intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Inari Medical stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
| Accumulation Distribution | 2864.63 | |||
| Daily Balance Of Power | (0.06) | |||
| Rate Of Daily Change | 1.0 | |||
| Day Median Price | 79.68 | |||
| Day Typical Price | 79.68 | |||
| Price Action Indicator | 0.005 | |||
| Period Momentum Indicator | (0.01) |
Inari Medical Corporate Filings
| 17th of January 2025 Other Reports | ViewVerify | |
| 15th of January 2025 Other Reports | ViewVerify | |
F4 | 8th of January 2025 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
| 7th of January 2025 Other Reports | ViewVerify |
Inari Stock media impact
Far too much social signal, news, headlines, and media speculation about Inari Medical that are available to investors today. That information is available publicly through Inari media outlets and privately through word of mouth or via Inari internal channels. However, regardless of the origin, that massive amount of Inari data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Inari Medical news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Inari Medical relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Inari Medical's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Inari Medical alpha.
Inari Medical Sentiment by Major News Outlets
Investor sentiment, mood or attitude towards Inari Medical can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Inari Medical Historical Investor Sentiment
Investor biases related to Inari Medical's public news can be used to forecast risks associated with an investment in Inari. The trend in average sentiment can be used to explain how an investor holding Inari can time the market purely based on public headlines and social activities around Inari Medical. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Inari Medical's market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Inari Medical and other traded tickers. The bigger the bubble, the more accurate the estimated score. Higher bars for a given day show more participation in the average Inari Medical news discussions. The higher the estimate score, the more favorable the investor's outlook on Inari Medical.
Inari Medical Corporate Management
| Angela JD | General Secretary | Profile | |
| Tara Dunn | Senior Development | Profile | |
| John Borrell | Senior Sales | Profile | |
| Kevin Strange | Accounting, Finance | Profile | |
| Janet Byk | VP Accounting | Profile | |
| John CFA | Vice Relations | Profile | |
| Karen Silva | Vice Accounting | Profile |
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Inari Medical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. For more detail on how to invest in Inari Stock please use our How to Invest in Inari Medical guide.You can also try the Economic Indicators module to top statistical indicators that provide insights into how an economy is performing.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Inari Medical. If investors know Inari will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Inari Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.84) | Earnings Share (1.35) | Revenue Per Share | Quarterly Revenue Growth 0.214 | Return On Assets |
The market value of Inari Medical is measured differently than its book value, which is the value of Inari that is recorded on the company's balance sheet. Investors also form their own opinion of Inari Medical's value that differs from its market value or its book value, called intrinsic value, which is Inari Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Inari Medical's market value can be influenced by many factors that don't directly affect Inari Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
In summary, please note that there is a difference between Inari Medical's value and its price, as these two are different measures arrived at by various means. Investors typically determine if Inari Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Inari Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.